Walgreen (WAG) Dec. Sales Fell 4%; Front-End Comps Down 2.3%
Tweet
Share
E-mail
Walgreen Company (NYSE: WAG) reports December sales fell 4 percent to $6.71 billion.
Total front-end sales decreased 1.3 percent compared with the same month in fiscal 2012, while comparable store front-end sales decreased 2.3 percent. Customer traffic in comparable stores decreased 4.0 percent while basket size increased 1.7 percent.
Prescriptions filled at comparable stores decreased by 2.3 percent in December and were flat on a day-fall adjusted (DFA) basis. This year’s December had one additional Sunday and Monday and one fewer Thursday and Friday compared with December 2011, negatively impacting prescriptions filled in comparable stores by 2.3 percentage points. DFA prescriptions filled at comparable stores were positively impacted by 1.4 percentage points due to the higher incidence of flu in this year’s December and 0.7 percentage point due to more flu shots administered in the month.
December pharmacy sales decreased 4.9 percent, while comparable store pharmacy sales decreased 8.9 percent and by a day-fall adjusted (DFA) 6.6 percent. Calendar day shifts negatively impacted pharmacy sales in comparable stores by 2.3 percentage points. DFA comparable store pharmacy sales were negatively impacted by 5.7 percentage points due to generic drug introductions in the last 12 months. Pharmacy sales accounted for 56.7 percent of total sales for the month.
Flu shots administered at pharmacies and clinics season-to-date were nearly 5.5 million versus approximately 5.3 million last year.
Sales in comparable stores decreased by 6.1 percent in December. Calendar day shifts negatively impacted total comparable sales by 1.3 percentage points, while generic drug introductions in the last 12 months negatively impacted total comparable sales by 3.2 percentage points.
Registrations for Walgreens Balance™ Rewards loyalty program, which launched in September, totaled nearly 49 million through December.
Calendar 2012 sales were $70.51 billion, a decrease of 3.7 percent from $73.19 billion in 2011.
Fiscal 2013 year-to-date sales for the first four months were $24.03 billion, down 4.4 percent from $25.15 billion in the comparable period in fiscal 2012.
Walgreens opened seven stores during December, acquired one and closed four.
At Dec. 31, Walgreens operated 8,524 locations in all 50 states, the District of Columbia, Puerto Rico and Guam. That includes 8,061 drugstores, 243 more than a year ago, including 107 net stores acquired over the last 12 months. The company also operates infusion and respiratory services facilities, specialty pharmacies and mail service facilities. Its Take Care Health Systems subsidiary manages more than 700 in-store convenient care clinics and worksite health and wellness centers.
Total front-end sales decreased 1.3 percent compared with the same month in fiscal 2012, while comparable store front-end sales decreased 2.3 percent. Customer traffic in comparable stores decreased 4.0 percent while basket size increased 1.7 percent.
Prescriptions filled at comparable stores decreased by 2.3 percent in December and were flat on a day-fall adjusted (DFA) basis. This year’s December had one additional Sunday and Monday and one fewer Thursday and Friday compared with December 2011, negatively impacting prescriptions filled in comparable stores by 2.3 percentage points. DFA prescriptions filled at comparable stores were positively impacted by 1.4 percentage points due to the higher incidence of flu in this year’s December and 0.7 percentage point due to more flu shots administered in the month.
December pharmacy sales decreased 4.9 percent, while comparable store pharmacy sales decreased 8.9 percent and by a day-fall adjusted (DFA) 6.6 percent. Calendar day shifts negatively impacted pharmacy sales in comparable stores by 2.3 percentage points. DFA comparable store pharmacy sales were negatively impacted by 5.7 percentage points due to generic drug introductions in the last 12 months. Pharmacy sales accounted for 56.7 percent of total sales for the month.
Flu shots administered at pharmacies and clinics season-to-date were nearly 5.5 million versus approximately 5.3 million last year.
Sales in comparable stores decreased by 6.1 percent in December. Calendar day shifts negatively impacted total comparable sales by 1.3 percentage points, while generic drug introductions in the last 12 months negatively impacted total comparable sales by 3.2 percentage points.
Registrations for Walgreens Balance™ Rewards loyalty program, which launched in September, totaled nearly 49 million through December.
Calendar 2012 sales were $70.51 billion, a decrease of 3.7 percent from $73.19 billion in 2011.
Fiscal 2013 year-to-date sales for the first four months were $24.03 billion, down 4.4 percent from $25.15 billion in the comparable period in fiscal 2012.
Walgreens opened seven stores during December, acquired one and closed four.
At Dec. 31, Walgreens operated 8,524 locations in all 50 states, the District of Columbia, Puerto Rico and Guam. That includes 8,061 drugstores, 243 more than a year ago, including 107 net stores acquired over the last 12 months. The company also operates infusion and respiratory services facilities, specialty pharmacies and mail service facilities. Its Take Care Health Systems subsidiary manages more than 700 in-store convenient care clinics and worksite health and wellness centers.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Accel Entertainment CEO joins company board of directors
- BofA: AI adoption shows limited impact on overall job growth
- Wolfe Research says AI productivity gains won't solve U.S. debt
Create E-mail Alert Related Categories
Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
